D. Kimberlin

发表

Nelson's Pediatric Antimicrobial Therapy

J. Bradley, J. Nelson, D. Kimberlin, 2012 .

Neonatal herpes simplex virus infection: epidemiology and treatment.

D. Kimberlin, S. James, 2015, Clinics in perinatology.

Neonatal Herpes Simplex Virus Infection.

D. Kimberlin, S. James, 2015, Infectious disease clinics of North America.

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

S. Soong, D. Powell, W. Gruber, 2001, Pediatrics.

Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections

Lucia H. Lee, C. Byington, B. Bell, 2009, Pediatrics.

Herpes simplex viruses.

B Roizman, B. Roizman, D. Kimberlin, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical practice. Genital herpes.

D. Rouse, D. Kimberlin, Dwight J Rouse, 2004, The New England journal of medicine.

Vaccine Delays, Refusals, and Patient Dismissals: A Survey of Pediatricians

K. O'Connor, I. Aban, D. Kimberlin, 2016, Pediatrics.

Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of COVID-19 in Children and Adolescents

P. Zachariah, Mari M Nakamura, W. Huskins, 2021, Journal of the Pediatric Infectious Diseases Society.

Advances in the treatment of neonatal herpes simplex infections

D. Kimberlin, 2001, Reviews in medical virology.

Lucia H. Lee, H. Davies, C. Byington, 2014, Pediatrics.

Control of varicella disease, version 2.0.

D. Kimberlin, 2011, The Journal of infectious diseases.

Prevention of Varicella: Update of Recommendations for Use of Quadrivalent and Monovalent Varicella Vaccines in Children

C. Byington, K. Edwards, Y. Maldonado, 2011, Pediatrics.

Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule

A. Schuchat, J. Swanson, R. Baltimore, 2007, Pediatrics.

Pathogenesis and disease

C. Prober, D. Kimberlin, R. Whitley, 2007 .

Assessing the Febrile Child for Serious Infection: A Step Closer to Meaningful Rapid Results

D. Kimberlin, Claudette L Poole, 2017, Pediatrics.

Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial.

K. Monroe, D. Kimberlin, A. Klasner, 2003, Pediatrics.

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.

J. Bale, S. Spector, S. Soong, 1996, The Pediatric infectious disease journal.

Medical Versus Nonmedical Immunization Exemptions for Child Care and School Attendance

Mandy A. Allison, Elizabeth A. Sobczyk, H. Davies, 2016, Pediatrics.

Variation in Diagnostic Testing and Empiric Acyclovir Use for HSV Infection in Febrile Infants.

Samir Shah, S. Mahant, A. Schondelmeyer, 2021, Hospital pediatrics.

C. Byington, A. Schuchat, R. Frenck, 2008, Pediatrics.

The Role of Immunoprophylaxis in the Reduction of Disease Attributable to Respiratory Syncytial Virus

C. Hall, M. Brady, J. Bocchini, 2009, Pediatrics.

Recommendations for Prevention and Control of Influenza in Children, 2013–2014

Lucia H. Lee, H. Davies, C. Byington, 2013, Pediatrics.

Red Book: 2018-2021 report of the committee on infectious diseases.

R. Lynfield, M. Sawyer, E. Barnett, 2018 .

Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection — United States, October 2017

R. DeBiasi, J. Bale, S. Rasmussen, 2017, MMWR. Morbidity and mortality weekly report.

Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.

R. Jacobs, J. van der Walt, S. Weller, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.

D. Kimberlin, S. Stagno, 2020, JAMA.

Herpes simplex encephalitis: children and adolescents.

D. Kimberlin, R. Whitley, 2005, Seminars in pediatric infectious diseases.

The Use of Systemic Fluoroquinolones

M. Rennels, R. Baltimore, R. Frenck, 2006, Pediatrics.

Molecular diagnosis of viral infections of the central nervous system.

J. Romero, D. Kimberlin, 2003, Clinics in laboratory medicine.

Authors’ Response Re: Clarifying Costs and Benefits of Respiratory Syncytial Virus Immunoprophylaxis

D. Kimberlin, H. Meissner, 2014, Pediatrics.

RSV Immunoprophylaxis: Does the Benefit Justify the Cost?

D. Kimberlin, H. Meissner, H. C. Meissner, 2013, Pediatrics.

Recommendations for Administering Hepatitis A Vaccine to Contacts of International Adoptees

C. Byington, K. Edwards, Y. Maldonado, 2011, Pediatrics.

Protein synthesis-dependent induction of interleukin-1β by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells

P. Nisen, G. Mccracken, D. Kimberlin, 1995, Journal of Clinical Immunology.

Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.

Mary A. Worthington, N. Tofil, D. Kimberlin, 2009, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Herpes simplex viruses: is a vaccine tenable?

B. Roizman, D. Kimberlin, R. Whitley, 2002, The Journal of clinical investigation.

Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine

Lucia H. Lee, C. Byington, B. Bell, 2009, Pediatrics.

Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age

O. Ramilo, G. Storch, R. Jacobs, 2010, The Pediatric infectious disease journal.

Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older

H. Davies, C. Byington, R. Lynfield, 2016, Pediatrics.

Policy Statement: Antibiotic Stewardship in Pediatrics.

Prachi Singh, R. Lynfield, P. Tamma, 2021, Journal of the Pediatric Infectious Diseases Society.

Assays for antiviral drug resistance.

S. Spector, A. Hay, D. Kimberlin, 1995, Antiviral research.

Cytomegalovirus variation among newborns treated with valganciclovir.

D. Kimberlin, S. Ross, G. Clement Dobbins, 2022, Antiviral research.

Varicella-zoster vaccine for the prevention of herpes zoster.

D. Kimberlin, R. Whitley, 2007, The New England journal of medicine.

Neonatal Brain Injury From SARS-CoV-2: Fact or Fiction?

K. Puopolo, D. Kimberlin, 2021, The Pediatric infectious disease journal.

Policy Statement—Recommendations for the Prevention and Treatment of Influenza in Children, 2009–2010

Lucia H. Lee, C. Byington, B. Bell, 2009, Pediatrics.

Recommendations for Prevention and Control of Influenza in Children, 2016–2017

C. Byington, K. Edwards, Y. Maldonado, 2016, Pediatrics.

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.

M. Lucero, S. Madhi, H. Zar, 2020, The New England journal of medicine.

Neonatal Herpes Simplex Infection

D. Kimberlin, 2004, Clinical Microbiology Reviews.

Oseltamivir dosing for influenza infection in premature neonates.

E. Acosta, D. Kimberlin, R. Whitley, 2010, The Journal of infectious diseases.

Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine

J. Swanson, R. Baltimore, R. Frenck, 2006, Pediatrics.

Antiviral therapy options critical for high-risk patients with influenza

M. Brady, H. Bernstein, J. Bradley, 2012, AAP News.

Maternal and Neonatal Herpes Simplex Virus Infections

D. Kimberlin, Swetha Pinninti, 2013, American Journal of Perinatology.

Quantitative herpes simplex virus concentrations in neonatal infection.

D. Kimberlin, S. James, 2015, The Journal of pediatrics.

Clinical outcome and the role of antivirals in congenital cytomegalovirus infection.

D. Kimberlin, S. Ross, Shannon A. Ross, 2021, Antiviral research.

Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.

D. Kimberlin, R. Whitley, S. James, 2009, Antiviral research.

Diagnosis of herpes simplex virus infections of the CNS

D. Kimberlin, 2005, Expert review of molecular diagnostics.

Herpes simplex virus infections of the central nervous system.

D. Kimberlin, 2003, Seminars in pediatric infectious diseases.

Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis

P. Sánchez, G. Cloud, E. Capparelli, 2003, The Pediatric infectious disease journal.

Antiviral resistance in clinical practice.

D. Richman, C. Crumpacker, F. Hayden, 1995, Antiviral research.

Antiviral treatment of childhood influenza: an update

J. Bradley, D. Kimberlin, Amaran Moodley, 2018, Current opinion in pediatrics.

Treatment of viral infections during pregnancy and the neonatal period.

D. Kimberlin, R. Whitley, 1997, Clinics in perinatology.

Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cells.

P. Nisen, G. Mccracken, D. Kimberlin, 1995, Immunological investigations.

Breast Milk and COVID-19: What Do We Know?

K. Puopolo, D. Kimberlin, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease.

D. Kimberlin, 1998, The Pediatric Infectious Disease Journal.

Human herpesvirus-6: neurologic implications of a newly-described viral pathogen.

D. Kimberlin, R. Whitley, 1998, Journal of neurovirology.

A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.

P. Sánchez, E. Acosta, R. Lawrence, 2016, Journal of the Pediatric Infectious Diseases Society.

Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

C. Byington, M. Brady, M. Jackson, 2010, Pediatrics.

Prevention of Human Papillomavirus Infection: Provisional Recommendations for Immunization of Girls and Women With Quadrivalent Human Papillomavirus Vaccine

A. Schuchat, J. Swanson, R. Baltimore, 2007, Pediatrics.

Models of antiviral resistance.

R. Sidwell, D. Kimberlin, R. Whitley, 1995, Antiviral research.

R. Baltimore, R. Frenck, L. Rubin, 2007, Pediatrics.

Determination of Appropriate Dosing of Influenza Drugs in Pediatric Patients

E. Acosta, D. Kimberlin, 2010, Clinical pharmacology and therapeutics.

Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.

D. Kimberlin, R. Whitley, Lauren B Nassetta, 2009, The Journal of antimicrobial chemotherapy.

Herpes simplex virus infections of the newborn.

D. Kimberlin, 2007, Seminars in perinatology.

Herpes simplex virus infections in neonates and early childhood.

D. Kimberlin, 2005, Seminars in pediatric infectious diseases.

Neonatal herpes: what have we learned.

D. Kimberlin, R. Whitley, 2005, Seminars in pediatric infectious diseases.

204 – Herpes Simplex Virus

C. Prober, D. Kimberlin, 2012 .

Herpes simplex virus.

D. Kimberlin, 2006 .

Active Genital Herpes Lesions Guidance on Management of Asymptomatic Neonates Born to Women With

D. Kimberlin, J. Baley, 2013 .

Neonatal herpes simplex virus infections.

D. Kimberlin, Swetha Pinninti, 2013, Pediatric clinics of North America.

Chapter 12 – Neonatal Herpes Simplex Virus and Congenital Cytomegalovirus Infections

D. Kimberlin, 2012 .

Impact of human coronavirus infections on paediatric patients at a tertiary paediatric hospital: a retrospective study of the prepandemic era

D. Kimberlin, R. Whitley, S. James, 2023, Journal of Hospital Infection.

The scarlet H.

D. Kimberlin, 2014, The Journal of infectious diseases.

Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series.

C. Leach, D. Kimberlin, R. Tolan, 2012, The Journal of pediatrics.

Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2006–2007

R. Baltimore, R. Frenck, L. Rubin, 2007, Pediatrics.

Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.

P. Sánchez, E. Acosta, J. Englund, 2012, The Journal of infectious diseases.

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children Now Online

A. Moscicki, L. Mofenson, K. Edwards, 2013, Morbidity and Mortality Weekly Report.

295 – Antiviral Agents

D. Kimberlin, 2018 .

Oral acyclovir suppression and neurodevelopment after neonatal herpes.

D. Powell, P. Sánchez, G. Storch, 2011, The New England journal of medicine.

Congenital and Acquired Infections in the Neonate

D. Kimberlin, P. Hoeger, S. James, 2019 .

Neonatal herpes simplex virus infections.

D. Kimberlin, Swetha Pinninti, 2013, Pediatric clinics of North America.

Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.

D. Kimberlin, J. Baley, 2016, Pediatrics.

When should you initiate acyclovir therapy in a neonate?

D. Kimberlin, 2008, The Journal of pediatrics.

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

S. Soong, D. Powell, W. Gruber, 2001, Pediatrics.

Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

D. Powell, L. Corey, R. Jacobs, 1996, The Journal of infectious diseases.

Antiviral resistance: mechanisms, clinical significance, and future implications.

D. Kimberlin, R. Whitley, 1996, The Journal of antimicrobial chemotherapy.

Red book : 2015 report of the Committee on Infectious Diseases

C. Baker, L. Pickering, D. Kimberlin, 2016 .

Balancing Risks in the Time of COVID-19.

K. Puopolo, D. Kimberlin, 2020, JAMA pediatrics.

Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Antiviral therapies in children: has their time arrived?

D. Kimberlin, 2005, Pediatric clinics of North America.

Antiviral therapy for cytomegalovirus infections in pediatric patients.

D. Kimberlin, 2002, Seminars in pediatric infectious diseases.

Acyclovir derivatives and other new antiviral agents

D. Kimberlin, 2001 .

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.

S. Soong, P. Sánchez, R. Jacobs, 2003, The Journal of pediatrics.

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Eneida A. Mendonça, Lucia H. Lee, H. Davies, 2014, Pediatrics.

Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment

D. Kimberlin, C. Marsico, 2017, Italian Journal of Pediatrics.

Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.

Wendy J M van Zuylen, T. Lazzarotto, S. Boppana, 2017, The Lancet. Infectious diseases.

Neonatal Herpes Simplex Virus, Congenital Cytomegalovirus, and Congenital Zika Virus Infections

D. Kimberlin, Nazia Kabani, 2019, Neurology.

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.

S. Soong, P. Sánchez, R. Jacobs, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.

P. Sánchez, E. Acosta, R. Jacobs, 2008, The Journal of infectious diseases.

Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population

Moriah L. Szpara, Daniel W. Renner, M. Weitzman, 2019, mSphere.

Antiviral Approaches for the Treatment of Herpes Simplex Virus Infections in Newborn Infants.

D. Kimberlin, Claudette L. Poole, 2018, Annual review of virology.

Acyclovir Dosing in the Neonatal Period and Beyond.

D. Kimberlin, 2013, Journal of the Pediatric Infectious Diseases Society.

Herpes simplex virus, meningitis and encephalitis in neonates.

D. Kimberlin, 2004, Herpes : the journal of the IHMF.

Guidance on Management of Asymptomatic Neonates Born to Women With Active Genital Herpes Lesions

D. Kimberlin, J. Baley, 2013, Pediatrics.

Prophylaxis and treatment of herpesvirus infections in children

D. Kimberlin, R. Whitley, 1997 .

Molecular mechanisms of antiviral resistance.

D M Coen, R. Lamb, E. Emini, 1995, Antiviral research.

13 Antiviral Therapy

D. Kimberlin, R. Whitley, B. Rha, 2010 .

Drinking Water From Private Wells and Risks to Children.

M. Ardura, A. Woolf, R. Lynfield, 2023, Pediatrics.

Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

P. Zachariah, P. Tamma, Mari M Nakamura, 2020, Journal of the Pediatric Infectious Diseases Society.

Advances in the Development of Therapeutics for Cytomegalovirus Infections.

L. Kauvar, R. Leavitt, E. Acosta, 2020, The Journal of infectious diseases.

Antiretroviral Pharmacokinetics in the Paediatric Population

G. Aldrovandi, E. Acosta, D. Kimberlin, 2002, Clinical pharmacokinetics.

Antiviral Drugs in Newborn and Children.

D. Kimberlin, Claudette L. Poole, 2017, Pediatric clinics of North America.

Pathogenesis of Non-Zika Congenital Viral Infections.

W. Britt, S. Boppana, K. Fowler, 2017, The Journal of infectious diseases.

Pharmacotherapy of recurrent respiratory papillomatosis

D. Kimberlin, 2002, Expert opinion on pharmacotherapy.

Ganciclovir Population Pharmacokinetics in Neonates Following Intravenous Administration of Ganciclovir and Oral Administration of a Liquid Valganciclovir Formulation

P. Sánchez, E. Acosta, R. Jacobs, 2007, Clinical pharmacology and therapeutics.

Acyclovir Dosing and Acute Kidney Injury: Deviations and Direction.

D. Kimberlin, I. Steinberg, 2015, The Journal of pediatrics.

Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.

D. Kimberlin, 2004, Antiviral research.

Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy.

D. Kimberlin, D. Malis, 2000, Antiviral research.

Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.

W. Britt, S. Soong, P. Sánchez, 2005, The Journal of infectious diseases.

Valganciclovir for symptomatic congenital cytomegalovirus disease.

R. DeBiasi, P. Griffiths, P. Sánchez, 2015, The New England journal of medicine.

Sequelae Following Postnatally Acquired Cytomegalovirus Infection in Very Low-Birth-Weight Neonates: Back to the Future.

D. Kimberlin, 2015, JAMA pediatrics.

Management of neonatal herpes simplex virus infection and exposure

D. Kimberlin, Swetha Pinninti, 2014, Archives of Disease in Childhood: Fetal and Neonatal Edition.

Meningitis in the neonate

D. Kimberlin, 2002, Current treatment options in neurology.

Clinical Investigator Training Program (CITP) – A practical and pragmatic approach to conveying clinical investigator competencies and training to busy clinicians

G. Naik, J. Willig, M. Dransfield, 2020, Contemporary clinical trials communications.

Comprar Red Book 2009 PLUS E-edition Report of the Committee on Infectious Diseases | Sarah S. Long | 9781581103472 | American Academy of Pediatrics

Larry K. Pickering, C. Baker, L. Pickering, 2009 .

Updated Recommendations on the Use of Meningococcal Vaccines

Lucia H. Lee, H. Davies, C. Byington, 2014, Pediatrics.

D. Powell, L. Corey, R. Jacobs, 1996, The Journal of infectious diseases.

Clinical Markers and Outcomes of Neonates With Herpes Simplex Virus Deoxyribonucleic Acid Persistence in Cerebrospinal Fluid in Disseminated and Central Nervous System Infection

M. Jackson, D. Kimberlin, A. Myers, 2018, Journal of the Pediatric Infectious Diseases Society.

Neonatal Herpes Simplex Virus Disease: Updates and Continued Challenges.

D. Kimberlin, S. James, Nicole L Samies, 2021, Clinics in perinatology.

Mother-to-Child Transmission of Herpes Simplex Virus.

D. Kimberlin, S. James, J. Sheffield, 2014, Journal of the Pediatric Infectious Diseases Society.

Host Defense Mechanisms Against Viruses

M. B. Guffey, D. Kimberlin, M. Guffey, 2011 .

Genotypic and phenotypic diversity within the neonatal HSV-2 population

Moriah L. Szpara, Daniel W. Renner, M. Weitzman, 2018 .

Physicians’ perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome

K. Edwards, G. Amarilyo, F. Dedeoglu, 2017, Rheumatology International.

Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.

J. Kahn, P. Sánchez, N. Patel, 2004, The Journal of infectious diseases.

Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment.

D. Kimberlin, 2007, Herpes : the journal of the IHMF.

Rabies-Prevention Policy Update: New Reduced-Dose Schedule

C. Byington, K. Edwards, Y. Maldonado, 2011, Pediatrics.

Closer to Universal Newborn Screening for Congenital Cytomegalovirus Infection but Far Away from Antiviral Therapy in All Infected Infants.

D. Kimberlin, S. Long, S. Ross, 2018, The Journal of pediatrics.

Valganciclovir for Congenital Cytomegalovirus.

E. Acosta, I. Aban, D. Kimberlin, 2015, The New England journal of medicine.

109 Human Herpes Viruses Type 6 and 7

D. Kimberlin, 2012 .

Human Herpes Viruses Type 6 and 7

D. Kimberlin, 2012 .

Antiviral Therapy and Prophylaxis for Influenza in Children

R. Baltimore, R. Frenck, L. Rubin, 2007, Pediatrics.

Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants

M. Lucero, S. Madhi, H. Zar, 2020, The New England journal of medicine.

Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients

G. Aldrovandi, E. Acosta, R. Yogev, 2003, The Pediatric infectious disease journal.

Human Herpesviruses: HSV-1 AND 2: Pathogenesis and disease

C. Prober, D. Kimberlin, R. Whitley, 2007 .

Advances in the prevention and treatment of congenital cytomegalovirus infection

D. Kimberlin, S. James, 2016, Current opinion in pediatrics.

Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.

P. Sánchez, R. Jacobs, J. Englund, 2018, The Journal of infectious diseases.

The Posology of Oseltamivir in Infants With Influenza Infection Using a Population Pharmacokinetic Approach

B. Rath, P. Sánchez, L. Gibiansky, 2014, Clinical pharmacology and therapeutics.

Infection Prevention and Control in Pediatric Ambulatory Settings

A. Schuchat, J. Swanson, R. Baltimore, 2007, Pediatrics.

Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants.

M. Lucero, S. Madhi, H. Zar, 2020, The New England journal of medicine.

COVID-19 Vaccination of Adolescents and Young Adults of Color: Viewing Acceptance and Uptake With a Health Equity Lens

M. Trent, G. Zimet, T. Coyne-Beasley, 2021, Journal of Adolescent Health.

Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007–2008

C. Byington, A. Schuchat, R. Frenck, 2008, Pediatrics.

Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2008–2009

C. Byington, R. Frenck, L. Rubin, 2008, Pediatrics.

Neonatal HSV infections: the global picture.

D. Kimberlin, 2004, Herpes : the journal of the IHMF.

Fulminant Haemophilus Influenzae Type a Infection in a 4-year-old with Previously Undiagnosed Asplenic Heterotaxy.

D. Kimberlin, E. Schmit, A. Headrick, 2017, The Pediatric infectious disease journal.

Recommendations for Prevention and Control of Influenza in Children, 2012–2013

Lucia H. Lee, H. Davies, C. Byington, 2012, Pediatrics.

Update From the Advisory Committee on Immunization Practices.

M. Sawyer, D. Kimberlin, P. Iroh Tam, 2016, Journal of the Pediatric Infectious Diseases Society.

Update From the Advisory Committee on Immunization Practices.

J. Englund, D. Kimberlin, S. James, 2014, Journal of the Pediatric Infectious Diseases Society.

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

R. DeBiasi, P. Griffiths, P. Sánchez, 2015 .

Update From the Advisory Committee on Immunization Practices.

D. Kimberlin, J. Campbell, S. O'Leary, 2018, Journal of the Pediatric Infectious Diseases Society.

Update From the Advisory Committee on Immunization Practices.

Y. Maldonado, D. Kimberlin, S. O'Leary, 2018, Journal of the Pediatric Infectious Diseases Society.

Intravenous Zanamivir in Hospitalized Patients With Influenza

R. DeBiasi, P. Yates, D. Shortino, 2017, Pediatrics.

The Tail Wagging the Dog (or the Challenges Faced When the Financing of Medicine Gets Ahead of the Science of Medicine)

D. Kimberlin, 2018, Journal of Clinical Microbiology.

Targeted antiviral prophylaxis with oseltamivir in a summer camp setting.

D. Redden, D. Kimberlin, P. Jester, 2010, Archives of pediatrics & adolescent medicine.

Preventing herpes simplex virus in the newborn.

D. Kimberlin, Swetha Pinninti, 2014, Clinics in perinatology.

Herpes Simplex Virus Infections

D. Kimberlin, 2012 .

Screening for Congenital Cytomegalovirus After Newborn Hearing Screening: What Comes Next?

S. Grosse, D. Kimberlin, S. Dollard, 2017, Pediatrics.

Antiviral therapy of HSV-1 and -2

D. Kimberlin, R. Whitley, 2007 .

erpes Simplex Virus Infections of the Newborn

D. Kimberlin, 2007 .

Preventing human papillomavirus-related cancers: we are all in this together.

I. Scarinci, J. Straughn, D. Kimberlin, 2017, American journal of obstetrics and gynecology.

Update From the Advisory Committee on Immunization Practices.

J. Englund, D. Kimberlin, E. Schlaudecker, 2013, Journal of the Pediatric Infectious Diseases Society.

Neonatal herpes simplex virus infections.

D. Kimberlin, Swetha Pinninti, 2018, Seminars in perinatology.

Meningococcal Conjugate Vaccines Policy Update: Booster Dose Recommendations

Lucia H. Lee, C. Byington, J. Swanson, 2011, Pediatrics.

Diagnosis of Herpes Simplex Virus in the Era of Polymerase Chain Reaction

D. Kimberlin, 2006, The Pediatric infectious disease journal.

295 – Antiviral Agents

D. Kimberlin, 2012 .

Recommendations for Prevention and Control of Influenza in Children, 2023-2024.

Juan D. Chaparro, M. Ardura, R. Lynfield, 2023, Pediatrics.

The Safety and Efficacy of High-Dose (HD) Acyclovir (ACV) in Neonatal Herpes Simplex Virus (HSV) Infections

S. Soong, D. Powell, W. Gruber, 1999 .

Antiviral resistance--an emerging problem.

D. Kimberlin, R. Whitley, 1995, Antiviral Research.

Why neonatal herpes matters.

D. Kimberlin, 2017, The Lancet. Global health.

Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009–2015

S. Mahant, A. Schondelmeyer, M. Hall, 2019, Pediatrics.

Neonatal Herpes Simplex Virus Infection

D. Kimberlin, Nazia Kabani, 2018 .

Neonatal Herpes Simplex Virus Infection

D. Kimberlin, Nazia Kabani, 2019, Infectious Disease and Pharmacology.

Delayed Recurrence of Herpes Simplex Virus Infection in the Central Nervous System After Neonatal Infection and Completion of Six Months of Suppressive Therapy

D. Kimberlin, S. Forgie, Baylee Henderson, 2017, Journal of the Pediatric Infectious Diseases Society.

Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth

C. Byington, T. Raju, R. Lynfield, 2017, Pediatrics.

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediat

A. Moscicki, L. Mofenson, G. Siberry, 2013, The Pediatric infectious disease journal.

Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.

Wendy J M van Zuylen, T. Lazzarotto, S. Boppana, 2017, Lancet. Infectious Diseases (Print).

Valganciclovir for symptomatic congenital cytomegalovirus disease.

R. DeBiasi, P. Sánchez, E. Acosta, 2015, The New England journal of medicine.

Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine

Lucia H. Lee, C. Byington, B. Bell, 2009, Pediatrics.

Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.

D. Kimberlin, R. Whitley, Lauren B Nassetta, 2009, The Journal of antimicrobial chemotherapy.

From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.

R. Frenck, R. Clover, H. Keyserling, 2009, Pediatrics.

C. Byington, M. Brady, M. Jackson, 2010, Pediatrics.

Summer 2023 ACIP Update: RSV Prevention and Updated Recommendations on Other Vaccines.

D. Kimberlin, Claudia Gaviria-Agudelo, Alexandra B. Yonts, 2023, Pediatrics.

204 – Herpes Simplex Virus

C. Prober, D. Kimberlin, 2018 .

P168 Remdesivir in the treatment of children 28 days to < 18 years of age hospitalised with COVID-19 in the CARAVAN study

C. Hedskog, D. Kimberlin, R. Humeniuk, 2022, ‘Infinity War’ – Ongoing clinical challenges in COVID-19.

Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey

D. Kimberlin, M. Chehade, Pierce Kuhnell, 2024, JMIR public health and surveillance.

H. Keyserling, D. Kimberlin, M. Glodé, 2011, Pediatrics.

Oral Valganciclovir Initiated beyond One Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.

D. Kimberlin, Kalyani Peri, P. Dennehy, 2024, The Journal of pediatrics.

Herpes simplex encephalitis: children and adolescents.

D. Kimberlin, Richard J. Whitley, 2005, Seminars in pediatric infectious diseases.